Navigation Links
CRESTOR(R) Reduced Risk of Blood Clots in the Veins
Date:3/29/2009

ORLANDO, Fla., March 29 /PRNewswire-FirstCall/ -- A new analysis from the JUPITER study shows that CRESTOR(R) (rosuvastatin calcium) 20mg significantly cut the risk of venous thromboembolism (VTE) by 43% (p =0.007) compared to placebo among men and women with low to normal cholesterol levels and elevated high-sensitivity C-reactive protein (hsCRP). This analysis was presented today at the 58th Annual American College of Cardiology Scientific Sessions (ACC) in Orlando, Florida, and published simultaneously in the New England Journal of Medicine.

Venous thromboembolism, a serious and sometimes fatal condition, occurs when a blood clot forms in a vein. The most common form of VTE is deep vein thrombosis (DVT), which occurs in the 'deep veins' usually in the legs or pelvis. An embolism is created if the clot travels through the venous system. Blood clots lodging in the lungs are known as a pulmonary embolism (PE). Estimates suggest that at least 350,000 and as many as 600,000 Americans annually develop DVT/PE, and at least 100,000 deaths are thought to be related to these diseases each year.

Additional results of this secondary endpoint analysis of JUPITER showed rosuvastatin 20mg produced a significant 55% (p=0.004) reduction in the risk of DVT and a non-significant 23% reduction in PE (p=0.42).

"This is the first time a statin has been shown to reduce the risk of VTE in a randomized, prospective study," said Alex Gold, MD, Executive Director of Clinical Development, AstraZeneca US. "This result is in addition to the effect on cardiovascular events already demonstrated by CRESTOR in the primary analysis of JUPITER."

Rosuvastatin 20mg was well tolerated in nearly 9,000 patients during the course of the JUPITER study.

ABOUT JUPITER:

JUPITER (Justification for the Use of statins in Primary prevention: an Intervention Trial Evaluating Rosuvastatin) was a
'/>"/>

SOURCE AstraZeneca
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Abbotts Phase III Sub-Group Analysis Shows Investigational TriLipix(TM) in Combination with CRESTOR(R) Improves Key Lipids in Patients with Mixed Dyslipidemia and Type 2 Diabetes
2. Phase III Study of Abbotts Investigational TriLipix(TM) in Combination With AstraZenecas CRESTOR(R) Meets Primary Endpoints on Key Lipids
3. New Analysis of METEOR Study Demonstrate Effects of AstraZenecas CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease
4. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
5. Cymbalta(R) Significantly Reduced Osteoarthritis Knee Pain in New Study
6. Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome
7. GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP
8. Dronedarone (Multaq(R)) Reduced the Incidence and Duration of Hospitalization in Patients with Atrial Fibrillation
9. Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus
10. ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments
11. Spherics, Inc. Announces Reduced Cognitive Impairment of Novel Extended Release Topiramate (SRx-502) as Compared to Topamax(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... ANGELES , July 11, 2014 /PRNewswire-iReach/ -- ... e-liquid, a vegetable-glycol solution for use in portable ... of the active ingredients in cannabis, cannabidiol offers ... personal vaporizer devices, and other vaporizer technology. ... Cannabis naturally contains 483 different compounds which ...
(Date:7/11/2014)... , July 11, 2014 Patient engagement ... and, consequently, organizations are turning to an assortment ... As part of this evolving approach to ... educate, communicate and engage patients throughout their experiences ... patient empowerment. By mapping the patient journey and ...
(Date:7/11/2014)... N.C. , July 11, 2014 ... approaches are evolving across industry sectors to better ... examining better ways to engage with and understand ... inform themselves and make critical purchasing decisions. ... firm, Best Practices, LLC, one area where organizations ...
Breaking Medicine Technology:VAPETEK Releases CBD-Infused eLiquid For The Consumer Market 2New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2New Technologies Transforming Consumer Marketing Research Playbook 2
... HORSHAM, Pa., Feb. 23, 2011 Centocor Ortho Biotech ... of Appeals for the Federal Circuit in Washington, D.C. ... the company $1.8 billion after finding Abbott Laboratories liable ... court ruled that the patent relating to Centocor anti-tumor ...
... 2011 Xenogenics Corporation ("Xenogenics"), a majority owned subsidiary ... pleased to announce it has retained the Emmes Group ... capital formation strategy to help finance expanded human clinical ... animal testing and initial human use, the Ideal BioStent™ ...
Cached Medicine Technology:Court of Appeals Overturns $1.8 Billion Patent Verdict for Centocor Ortho Biotech Inc. 2Xenogenics Corporation Retains the Emmes Group to Advise on Fund Raising Efforts 2Xenogenics Corporation Retains the Emmes Group to Advise on Fund Raising Efforts 3Xenogenics Corporation Retains the Emmes Group to Advise on Fund Raising Efforts 4
(Date:7/12/2014)... PA (PRWEB) July 12, 2014 Doylestown ... covering a variety of men’s health questions. Paddock ... specific to men, why women live longer than men, ... Men's Health Made Simple featured on Doylestown ... get a hernia at any age. If you notice ...
(Date:7/12/2014)... Dubai is buzzing with the announcement ... to the UAE. The National Basketball Association’s (NBA) ... the UAE from 28-31 October to lead the Kareem ... awareness. The event is being organized by Maven Marketing ... company based in Dubai. The announcement was made today ...
(Date:7/12/2014)... 12, 2014 Wright & Schulte LLC, an ... Just For Men Lawsuits (case #59776/2014), announces they have ... reports that allege the popular hair dye, Just For Men, ... their face, neck and other areas. In addition to detailing ... chemical burns , the advertisements being run by Wright & ...
(Date:7/12/2014)... Palm Beach, FL (PRWEB) July 12, 2014 ... variety of high-quality peptides that are used solely in ... To honor two successful years in business, Maxim Peptide, ... LLC, has just launched a new and updated website ... the research blog section has been updated with fascinating ...
(Date:7/11/2014)... July 12, 2014 Recently, MagicQuinceaneraDresses.com, the ... its new collection of 2014 Quinceanera dresses . ... who want to look fashionable without paying a large ... prices, up to 57% off. , The company’s online ... to get amazing special occasion outfits. In addition to ...
Breaking Medicine News(10 mins):Health News:Ivyland Medical Center’s Dr. Brad Paddock Offers Tips for Men’s Health 2Health News:Los Angeles Basketball Legend Headed to Dubai 2Health News:Los Angeles Basketball Legend Headed to Dubai 3Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 2Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 3Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 4Health News:Maxim Peptide Celebrates Second Anniversary Online with an Updated Website and Special Deals Section 2Health News:Cheap Quinceanera Dresses Now Available At MagicQuinceaneraDresses.com 2
... led by researchers from North Carolina State University ... properties into microneedles vanishingly thin needles that ... devices. Researchers expect the findings to spur development ... cause less pain, tissue damage and skin inflammation ...
... ... childhood crippler spinal muscular atrophy (SMA), is awarding a $250,000 research grant to Dr. ... Ohio State University. , ... (PRWEB) May 19, 2010 -- Richmond, Virginia-based FightSMA, a nonprofit dedicated to developing ...
... of conventional seed , TUESDAY, May 18 (HealthDay News) -- ... but a new British study finds that wild birds beg ... conventional wheat seed, which helps them pack in the protein. ... said in a news release from the school, were likely ...
... it,s committed to responsible online advertising , WEDNESDAY, May ... the latest new media technologies -- including cell phones, ... expanding digital universe -- to reach young drinkers, a ... be keeping up with the marketing trend, the report,s ...
... ... Experience, View Their Photos, and Learn What Footwear To Pack for an African Safari , ... Seattle, Wash. (PRWEB) May 17, 2010 -- Good ... online shoe retailer before embarking on her honeymoon, vowing to pack only five pairs of shoes ...
... The ... xSCC Skin, and xMM skin, respectively on Basal Cell Cancer, Squamous Cell Cancer, and Malignant ... that not only tracks and stores images of the skin, but also allows for recording ... ...
Cached Medicine News:Health News:New microneedle antimicrobial techniques may foster medical tech innovation 2Health News:FightSMA Awards $250,000 Grant to Gene Researcher at The Ohio State University 2Health News:Wild Birds Shun Organic Food 2Health News:Alcohol Companies Use New Media to Lure Young Drinkers: Report 2Health News:Alcohol Companies Use New Media to Lure Young Drinkers: Report 3Health News:Alcohol Companies Use New Media to Lure Young Drinkers: Report 4Health News:The Bachelor's Molly Malaney Blogs About Honeymoon at Onlineshoes.com 2Health News:The Bachelor's Molly Malaney Blogs About Honeymoon at Onlineshoes.com 3Health News:neXante Turns Apple's iPhone Into Skin Cancer Surveillance Support Tool And Health Record 2
Ovulation test for the rapid detection of LH in urine. Our ovulation tests, designed to accurately detect fertility in a user-friendly presentation, are also available for professional and over-the-c...
... Clinitek® 50 analyzer is ... physician offices and smaller ... consistency of state-of-the-art instrument-based ... more efficient way to ...
... The HemoPoint H2 Hemoglobin Measurement System ... of hemoglobin in arterial, venous, or ... and children in a professional point-of-care ... 3010-100 is indicated for use in ...
... Self-Sampling: ,Place the ImmunoDip into ... precise amount of sample needed for,an accurate ... run to completion,in 3 minutes. , ... color bands remain stable,for at least eight ...
Medicine Products: